BORRBangladesh Open Research Repository
SearchSubmitAboutContact
BORRResearch for a Better Bangladesh.
AboutSubmit PaperContactTermsPolicyGitHub

© 2026 Bangladesh Open Research Repository.

Filters

Sort By

Sort by relevanceSort by dateSort by citations
Year Range
to

Results for “"Suja Pillai"”

16 results

Plasticity of Cancer Stem Cell: Origin and Role in Disease Progression and Therapy Resistance

Verified

Plabon Kumar Das, Suja Pillai, Md. Abdur Rakib, Jahan Ara Khanam et al.

Journal: Stem Cell Reviews and ReportsYear: 2020Citations: 76

In embryonic development and throughout life, there are some cells can exhibit phenotypic plasticity. Phenotypic plasticity is the ability of cells to differentiate into multiple lineages. In normal development, plasticity is highly regulated whereas cancer cells re-activate this dynamic ability for...

Health SciencesMedicineOncologyOpen Access
Read Source

Implications of estrogen and its receptors in colorectal carcinoma

Verified

Plabon Kumar Das, Joti Saha, Suja Pillai, Alfred K. Lam et al.

Journal: Cancer MedicineYear: 2022Citations: 59

Estrogens have been implicated in the pathogenesis of various cancer types, including colorectal carcinoma (CRC). Estrogen receptors such as ERα and ERβ activate intracellular signaling cascades followed by binding to estrogen, resulting in important changes in cellular behaviors. The nuclear estrog...

Life SciencesBiochemistry, Genetics and Molecular BiologyGeneticsOpen Access
Read Source

Promoter hypermethylation inactivate tumor suppressor <i>FAM134B</i> and is associated with poor prognosis in colorectal cancer

Verified

Farhadul Islam, Vinod Gopalan, Suja Pillai, Cu‐Tai Lu et al.

Journal: Genes Chromosomes and CancerYear: 2018Citations: 31

The present study aims to examine promoter methylation status of FAM134B in a large cohort of patients with colorectal adenocarcinomas. The clinical significances and correlations of FAM134B promoter methylation with its expression are also analysed. Methylation-specific high-resolution melt-curve a...

Life SciencesBiochemistry, Genetics and Molecular BiologyMolecular BiologyOpen Access
Read Source

Natural Compounds Targeting Cancer Stem Cells: A Promising Resource for Chemotherapy

Verified

Plabon Kumar Das, Tasnim Zahan, Md. Abdur Rakib, Jahan Ara Khanam et al.

Journal: Anti-Cancer Agents in Medicinal ChemistryYear: 2019Citations: 29

BACKGROUND: Cancer Stem Cells (CSCs) are the subpopulation of cancer cells which are directly involved in drug resistance, metastases to distant organ and cancer recurrence. METHODS: A systematic literature search was conducted through various electronic databases including, Pubmed, Scopus, Google s...

Health SciencesMedicineOncologyOpen Access
Read Source

MicroRNAs, a Promising Target for Breast Cancer Stem Cells

Verified

Plabon Kumar Das, Mst. Ayesha Siddika, Saharia Yeasmin Asha, Suraiya Aktar et al.

Journal: Molecular Diagnosis & TherapyYear: 2019Citations: 29

Reactivation of the stem cell programme in breast cancer is significantly associated with persistent cancer progression and therapeutic failure. Breast cancer stem cells (BCSCs) are involved in the process of breast cancer initiation, metastasis and cancer relapse. Among the various important cues f...

Life SciencesBiochemistry, Genetics and Molecular BiologyCancer ResearchOpen Access
Read Source

Tumour suppressor properties of miR-15a and its regulatory effects on BCL2 and SOX2 proteins in colorectal carcinomas

Verified

Vinod Gopalan, Faeza Ebrahimi, Farhadul Islam, Jelena Vider et al.

Journal: Experimental Cell ResearchYear: 2018Citations: 28

Objectives: In this study, we aimed to investigate the expression pattern, clinicopathological significance and tumour suppressive properties of miR‐15a in patients with colorectal carcinomas. Methods: Tissue samples from 87 patients with primary colorectal carcinomas, 50 matched metastatic lymph no...

Life SciencesBiochemistry, Genetics and Molecular BiologyCancer ResearchOpen Access
Read Source

Novel Therapeutics Against Breast Cancer Stem Cells by Targeting Surface Markers and Signaling Pathways

Verified

Plabon Kumar Das, Md. Abdur Rakib, Jahan Ara Khanam, Suja Pillai et al.

Journal: Current Stem Cell Research & TherapyYear: 2019Citations: 20

BACKGROUND: Breast cancer remains to be one of the deadliest forms of cancers, owing to the drug resistance and tumor relapse caused by breast cancer stem cells (BCSCs) despite notable advancements in radio-chemotherapies. OBJECTIVES: To find out novel therapeutics against breast cancer stem cells b...

Health SciencesMedicineOncologyOpen Access
Read Source

Identification of Novel Mutations and Expressions of EPAS1 in Phaeochromocytomas and Paragangliomas

Verified

Farhadul Islam, Suja Pillai, Vinod Gopalan, Alfred K. Lam

Journal: GenesYear: 2020Citations: 16

Endothelial PAS domain-containing protein 1 (EPAS1) is an oxygen-sensitive component of the hypoxia-inducible factors (HIFs) having reported implications in many cancers by inducing a pseudo-hypoxic microenvironment. However, the molecular dysregulation and clinical significance of EPAS1 has never b...

Life SciencesBiochemistry, Genetics and Molecular BiologyCancer ResearchOpen Access
Read Source

Roles of long noncoding <scp>RNA</scp> in triple‐negative breast cancer

Verified

Plabon Kumar Das, Ayesha Siddika, K M Rashel, Abdul Auwal et al.

Journal: Cancer MedicineYear: 2023Citations: 14

INTRODUCTION: Long noncoding RNAs (lncRNAs) play crucial roles in regulating various hallmarks in cancers. Triple-negative (Estrogen receptor, ER; Human epidermal growth factor receptor 2, HER2; Progesterone receptor, PR) breast cancer (TNBC) is the most aggressive form of breast cancers with a poor...

Life SciencesBiochemistry, Genetics and Molecular BiologyCancer ResearchOpen Access
Read Source

Molecular Deregulation of EPAS1 in the Pathogenesis of Esophageal Squamous Cell Carcinoma

Verified

Farhadul Islam, Vinod Gopalan, Simon Law, Alfred K. Lam et al.

Journal: Frontiers in OncologyYear: 2020Citations: 14

Endothelial PAS domain-containing protein 1 (EPAS1) is an angiogenic factor and its implications have been reported in many cancers but not in esophageal squamous cell carcinoma (ESCC). Herein, we aim to examine the genetic and molecular alterations, clinical implications, and functional roles of EP...

Life SciencesBiochemistry, Genetics and Molecular BiologyCancer ResearchOpen Access
Read Source

Identification of novel mutations and functional impacts of EPAS1 in colorectal cancer

Verified

Farhadul Islam, Vinod Gopalan, Cu‐Tai Lu, Suja Pillai et al.

Journal: Cancer MedicineYear: 2021Citations: 12

Endothelial PAS domain-containing protein 1 (EPAS1) has implications in many cancers. However, the molecular behaviours, functional roles and mutational status of EPAS1 have never been studied in colorectal carcinoma (CRC). The study aims to examine the genetic alterations and functional roles of EP...

Health SciencesMedicinePulmonary and Respiratory MedicineOpen Access
Read Source

VEGF-A/VEGF-B/VEGF-C expressions in non-hereditary, non-metastatic phaeochromocytoma.

Verified

Ichiro Abe, Farhadul Islam, Chung Yau Lo, Victor Liew et al.

Journal: PubMedYear: 2021Citations: 4

Vascular endothelial growth factor (VEGF) is important in pathogenesis of different cancers. The aim of this study is to investigate the relationships between different VEGFs and clinicopathological factors in patients with phaeochromocytomas. Twenty patients (10 men; 10 women) with non-hereditary, ...

Health SciencesMedicineSurgeryOpen Access
Read Source

Editorial: Recent Advances in Pheochromocytoma and Paraganglioma: Molecular Pathogenesis, Clinical Impacts, and Therapeutic Perspective

Verified

Farhadul Islam, Ichiro Abe, Suja Pillai, Robert A. Smith et al.

Journal: Frontiers in EndocrinologyYear: 2021Citations: 1

In this Research Topic, we have collected recent developments in research into Pheochromocytomas and Paragangliomas (PPGLs), highlighting their molecular mechanisms, clinical manifestations, and improved therapeutic management.\n\nPPGLs are the primary types of neuroendocrine tumors, and are relativ...

Health SciencesMedicineSurgeryOpen Access
Read Source

Editorial: Recent advances in pheochromocytoma and paraganglioma: molecular pathogenesis, clinical impacts, and therapeutic perspective, volume II

Verified

Ichiro Abe, Farhadul Islam, Suja Pillai

Journal: Frontiers in EndocrinologyYear: 2025

PPGLs are relatively rare neuroendocrine tumors derived from chromaffin cells in the adrenal medulla and/or autonomic nervous system ganglia. Their clinical importance, including various associated complications, is due to catecholamine excess (1,2). Moreover, PPGLs could lead to pheochromocytoma mu...

Health SciencesMedicineSurgeryOpen Access
Read Source

Plasticity of Cancer Stem Cell

Verified

Suja Pillai, Nitai Roy

Year: 2023
Health SciencesMedicineOncology
Read Source

Roles of Long Noncoding RNA in Triple-Negative Breast Cancer

Verified

Plabon Kumar Das, Ayesha Siddika, Suja Pillai, Farhadul Islam

Journal: SSRN Electronic JournalYear: 2022
Life SciencesBiochemistry, Genetics and Molecular BiologyCancer ResearchOpen Access
Read Source
PreviousPage 1 of 1Next